T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19

Objective: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing global health emergency. T-cell receptors (TCRs) are crucial mediators of antiviral adaptive immunity. This study sought to comprehensively characterize the TCR reper...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xianliang Hou, Guangyu Wang, Wentao Fan, Xiaoyan Chen, Chune Mo, Yongsi Wang, Weiwei Gong, Xuyan Wen, Hui Chen, Dan He, Lijun Mo, Shaofeng Jiang, Minglin Ou, Haonan Guo, Hongbo Liu
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/e4863b545e454bbb99cb8e3dec682e83
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e4863b545e454bbb99cb8e3dec682e83
record_format dspace
spelling oai:doaj.org-article:e4863b545e454bbb99cb8e3dec682e832021-11-16T04:09:13ZT-cell receptor repertoires as potential diagnostic markers for patients with COVID-191201-971210.1016/j.ijid.2021.10.033https://doaj.org/article/e4863b545e454bbb99cb8e3dec682e832021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1201971221008201https://doaj.org/toc/1201-9712Objective: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing global health emergency. T-cell receptors (TCRs) are crucial mediators of antiviral adaptive immunity. This study sought to comprehensively characterize the TCR repertoire changes in patients with COVID-19. Methods: A large sample size multi-center randomized controlled trial was implemented to study the features of the TCR repertoire and identify COVID-19 disease-related TCR sequences. Results: It was found that some T-cell receptor beta chain (TCRβ) features differed markedly between COVID-19 patients and healthy controls, including decreased repertoire diversity, longer complementarity-determining region 3 (CDR3) length, skewed utilization of the TCRβ variable gene/joining gene (TRBV/J), and a high degree of TCRβ sharing in COVID-19 patients. Moreover, this analysis showed that TCR repertoire diversity declines with aging, which may be a cause of the higher infection and mortality rates in elderly patients. Importantly, a set of TCRβ clones that can distinguish COVID-19 patients from healthy controls with high accuracy was identified. Notably, this diagnostic model demonstrates 100% specificity and 82.68% sensitivity at 0–3 days post diagnosis. Conclusions: This study lays the foundation for immunodiagnosis and the development of medicines and vaccines for COVID-19 patients.Xianliang HouGuangyu WangWentao FanXiaoyan ChenChune MoYongsi WangWeiwei GongXuyan WenHui ChenDan HeLijun MoShaofeng JiangMinglin OuHaonan GuoHongbo LiuElsevierarticleCoronavirus disease 2019T-cell receptorSARS-CoV-2Adaptive immunityInfectious and parasitic diseasesRC109-216ENInternational Journal of Infectious Diseases, Vol 113, Iss , Pp 308-317 (2021)
institution DOAJ
collection DOAJ
language EN
topic Coronavirus disease 2019
T-cell receptor
SARS-CoV-2
Adaptive immunity
Infectious and parasitic diseases
RC109-216
spellingShingle Coronavirus disease 2019
T-cell receptor
SARS-CoV-2
Adaptive immunity
Infectious and parasitic diseases
RC109-216
Xianliang Hou
Guangyu Wang
Wentao Fan
Xiaoyan Chen
Chune Mo
Yongsi Wang
Weiwei Gong
Xuyan Wen
Hui Chen
Dan He
Lijun Mo
Shaofeng Jiang
Minglin Ou
Haonan Guo
Hongbo Liu
T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19
description Objective: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing global health emergency. T-cell receptors (TCRs) are crucial mediators of antiviral adaptive immunity. This study sought to comprehensively characterize the TCR repertoire changes in patients with COVID-19. Methods: A large sample size multi-center randomized controlled trial was implemented to study the features of the TCR repertoire and identify COVID-19 disease-related TCR sequences. Results: It was found that some T-cell receptor beta chain (TCRβ) features differed markedly between COVID-19 patients and healthy controls, including decreased repertoire diversity, longer complementarity-determining region 3 (CDR3) length, skewed utilization of the TCRβ variable gene/joining gene (TRBV/J), and a high degree of TCRβ sharing in COVID-19 patients. Moreover, this analysis showed that TCR repertoire diversity declines with aging, which may be a cause of the higher infection and mortality rates in elderly patients. Importantly, a set of TCRβ clones that can distinguish COVID-19 patients from healthy controls with high accuracy was identified. Notably, this diagnostic model demonstrates 100% specificity and 82.68% sensitivity at 0–3 days post diagnosis. Conclusions: This study lays the foundation for immunodiagnosis and the development of medicines and vaccines for COVID-19 patients.
format article
author Xianliang Hou
Guangyu Wang
Wentao Fan
Xiaoyan Chen
Chune Mo
Yongsi Wang
Weiwei Gong
Xuyan Wen
Hui Chen
Dan He
Lijun Mo
Shaofeng Jiang
Minglin Ou
Haonan Guo
Hongbo Liu
author_facet Xianliang Hou
Guangyu Wang
Wentao Fan
Xiaoyan Chen
Chune Mo
Yongsi Wang
Weiwei Gong
Xuyan Wen
Hui Chen
Dan He
Lijun Mo
Shaofeng Jiang
Minglin Ou
Haonan Guo
Hongbo Liu
author_sort Xianliang Hou
title T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19
title_short T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19
title_full T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19
title_fullStr T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19
title_full_unstemmed T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19
title_sort t-cell receptor repertoires as potential diagnostic markers for patients with covid-19
publisher Elsevier
publishDate 2021
url https://doaj.org/article/e4863b545e454bbb99cb8e3dec682e83
work_keys_str_mv AT xianlianghou tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT guangyuwang tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT wentaofan tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT xiaoyanchen tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT chunemo tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT yongsiwang tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT weiweigong tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT xuyanwen tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT huichen tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT danhe tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT lijunmo tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT shaofengjiang tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT minglinou tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT haonanguo tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
AT hongboliu tcellreceptorrepertoiresaspotentialdiagnosticmarkersforpatientswithcovid19
_version_ 1718426816997228544